Pharm 101: Erythromycin

Class

Macrolide antibiotic

  • Physical examination is normal
  • Aetiology is unknown but patients usually have a normal life span
  • Also referred to as “Effort Syndrome” as symptoms resemble those of fatigue following effort in healthy individuals

Pharmacodynamics
  • Inhibits bacterial protein synthesis by binding to 50S ribosomal RNA
  • Antibacterial action:
    • Bacteriostatic at low concentrations
    • Bactericidal at higher concentrations
  • Resistance is plasmid-encoded, mechanisms include:
    • Reduced membrane permeability or active efflux
    • Esterase production
    • Modification of ribosomal binding site
  • Physical examination is normal
  • Aetiology is unknown but patients usually have a normal life span
  • Also referred to as “Effort Syndrome” as symptoms resemble those of fatigue following effort in healthy individuals

Pharmacokinetics
  • Administration: PO, IV
  • Destroyed by gastric acid, must be enteric coated
  • Distributed widely except to brain/CSF
  • Crosses placenta
  • Half-life 1.5 hours normally, 5 hours in anuria
  • Biliary excretion, only 5% excreted in urine
    • Adjustment for renal failure not necessary
  • CYP3A4 enzyme inhibitor (see adverse effects)
  • Physical examination is normal
  • Aetiology is unknown but patients usually have a normal life span
  • Also referred to as “Effort Syndrome” as symptoms resemble those of fatigue following effort in healthy individuals

Antimicrobial activity
  • Gram positive organisms e.g. pneumococci, strep, staph
  • Mycoplasma pneumoniae, L pneumophila, Chlamydophila pneumoniae, Listeria monocytogenes
  • Gram negative organisms e.g. neisseria, bordatella pertussis, campylobacter
  • Treponema pallidum
  • Physical examination is normal
  • Aetiology is unknown but patients usually have a normal life span
  • Also referred to as “Effort Syndrome” as symptoms resemble those of fatigue following effort in healthy individuals

Adverse effects
  • Acute cholestatic hepatitis
  • Gastrointestinal upset (nausea/vomiting, anorexia, diarrhoea)
  • Allergic reactions e.g. fever, eosinophilia, rash
  • Drug interactions:
    • Increases concentration of warfarin, methylprednisolone due to CYP inhibition
    • Combination with terfenadine (H1 antagonist) causes lethal ventricular arrhythmia
    • Increases digoxin concentration in oral administration due to increased bioavailability
  • Physical examination is normal
  • Aetiology is unknown but patients usually have a normal life span
  • Also referred to as “Effort Syndrome” as symptoms resemble those of fatigue following effort in healthy individuals

Further reading
  • Physical examination is normal
  • Aetiology is unknown but patients usually have a normal life span
  • Also referred to as “Effort Syndrome” as symptoms resemble those of fatigue following effort in healthy individuals

References
  • Physical examination is normal
  • Aetiology is unknown but patients usually have a normal life span
  • Also referred to as “Effort Syndrome” as symptoms resemble those of fatigue following effort in healthy individuals

Pharm 101 700

Pharmacology 101

Top 200 drugs

MBBS (UWA) CCPU (RCE, Biliary, DVT, E-FAST, AAA) Emergency Medicine Advanced Trainee in Melbourne, Australia. Special interests in diagnostic and procedural ultrasound, medical education, and ECG interpretation. Editor-in-chief of the LITFL ECG Library. Twitter: @rob_buttner

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.